Sorafenib treatment in 13 patients with acute myeloid leukemia and activating FLT3 mutations in combination with chemotherapy or as monotherapy.
Schroeder
Thomas
T
University of Duesseldorf, Medical Faculty, Department of Haematology, Oncology and Clinical Immunology, Duesseldorf, Germany. thomas.schroeder@med.uni-duesseldorf.de
Zohren
Fabian
F
Saure
Christian
C
Bruns
Ingmar
I
Czibere
Akos
A
Safaian
Nelli Nancy
NN
Fenk
Roland
R
Haas
Rainer
R
Kobbe
Guido
G